![Andrew King](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew King
Chief Tech/Sci/R&D Officer at
JADE BIOSCIENCES, INC.
Net worth: 11 M $ as of 2026-08-30
Profile
Dr. Andrew King is a President-Research & Development at Jade Biosciences, Inc. and a Chief Scientific Officer at Jade Biosciences, Inc. (United States).
Dr. King was previously employed as a Chief Scientific Officer by Chinook Therapeutics, Inc. and a Senior Director-Discovery & Translational Biology by Ardelyx, Inc. He received his undergraduate degree from Murdoch University and a doctorate degree from Michigan State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-14 | 529,530 ( 0.83% ) | 11 M $ | 2026-08-30 |
Andrew King active positions
| Companies | Position | Start |
|---|---|---|
| JADE BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2025-04-27 |
Former positions of Andrew King
| Companies | Position | End |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-08-08 |
| ARDELYX, INC. | Corporate Officer/Principal | - |
Training of Andrew King
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
36
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Michigan State University
 Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Murdoch University
 Murdoch University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases | Health Technology |
- Stock Market
- Insiders
- Andrew King
